Ensign Peak Advisors
SGHT icon

Ensign Peak Advisors’s Sight Sciences SGHT Stock Holding History

Ensign Peak Advisors’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,910
Closed -$17K – 2348
2022
Q2 		$17K Hold
1,910
– – ﹤0.01% 2135
2022
Q1 		$22K Buy
+1,910
New +$29.4K ﹤0.01% 2175

Other funds holding SGHT

DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
KL
KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Ensign Peak Advisors's SGHT Position: Q3 2022 in Review

Ensign Peak Advisors sold out of Sight Sciences (SGHT) in Q3 2022, closing a stake of 1,910 shares — an estimated $17K sold.

Ensign Peak Advisors first reported a position in SGHT in Q1 2022 and held it in 2 quarters. The position peaked at $22K in Q1 2022. 68 funds tracked by Wall St. Rank hold SGHT as of Q3 2022.

  • Ensign Peak Advisors reported no remaining Sight Sciences position as of Q3 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 1,910 Sight Sciences shares in Q3 2022, an estimated $17K.
  • Ensign Peak Advisors first reported a position in Sight Sciences in Q1 2022 and held it in 2 quarters.
  • Ensign Peak Advisors's Sight Sciences position peaked at $22K in Q1 2022.
  • 68 funds tracked by Wall St. Rank held Sight Sciences as of Q3 2022.

Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.